Loading...
Market
What will Summit Therapeutics' market cap be at the end of 2024?
3
Resolution / Starting Odds
Below $15 billion • 25%
$15-$19.99 billion • 25%
$20-$24.99 billion • 25%
$25 billion or above • 25%
Publicly available financial data from stock market websites or financial news outlets
Story
Summit Therapeutics Raises $235M in Private Placement, Market Cap at $18.7B
Sep 12, 2024, 12:44 PM
Summit Therapeutics has raised $235 million through a private placement, issuing 10.35 million shares at $22.70 per share. Of the total amount, $79 million was raised by insiders, with the remaining $156 million coming from multiple leading biopharma institutional investors. The company's market capitalization is approximately $18.7 billion. This fundraising effort follows the company's strong pricing and substantial insider participation, reflecting confidence in its future prospects. The raise was also influenced by significant lung cancer data.
View original story
Similar markets
Yes • 50%
No • 50%
Less than $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $1.5 billion • 25%
More than $1.5 billion • 25%
Less than $100 million • 25%
$100 million to $500 million • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%
Below $3 billion • 25%
$3 billion to $5 billion • 25%
$5 billion to $7 billion • 25%
Above $7 billion • 25%
Less than $1 billion • 25%
$1 billion to $5 billion • 25%
$5 billion to $10 billion • 25%
More than $10 billion • 25%
Less than $150 billion • 25%
$150 billion to $170 billion • 25%
$170 billion to $190 billion • 25%
More than $190 billion • 25%
Below $3 billion • 25%
$3 billion to $3.99 billion • 25%
$4 billion to $4.99 billion • 25%
$5 billion or more • 25%
Yes • 50%
No • 50%
Below $20 • 25%
$20 to $40 • 25%
$40 to $60 • 25%
Above $60 • 25%
Less than $1 billion • 25%
$1 billion to $2 billion • 25%
$2 billion to $3 billion • 25%
More than $3 billion • 25%
Above $40 • 25%
Between $30 and $40 • 25%
Between $20 and $30 • 25%
Below $20 • 25%